Buy Aerie Pharmaceuticals Stock | AERI Stock Price & Latest News | Public.com
AERI

Aerie Pharmaceuticals

$0.00 (0.00%)Today
    View Aerie Pharmaceuticals (AERI) stock trends here

    About AERI

    Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105....Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.35
    -0.7
    -1.05
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.71

    Actual EPS
    Q1 2021

    Stats

    Market Cap$897,9M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$20.35
    1 Year Low$9.01
    Open$19.73
    High$20.46
    Low$19.48

    Buy any stock with any amount of money.

    Download the App
    Download the app